A Study to Compare the Pharmacokinetics and Safety/Tolerability of BR-UPS (Ulipristal Acetate) 5 mg Tablet With Inisia (Ulipristal Acetate) 5 mg Tablet
Clinical trial NCT03156127 · WITHDRAWN
Trial details
- NCT number
- NCT03156127
- Sponsor
- Boryung Pharmaceutical Co., Ltd
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-19
- Primary completion
- 2017-07-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.